We are live on
!
Find out more
HA
Hamel Associates Portfolio holdings
AUM
$363M
1-Year Est. Return
24.39%
This Fund
S&P 500
This Quarter
Est. Return
+2.64%
1 Year Est. Return
+24.39%
3 Year Est. Return
+50.64%
5 Year Est. Return
+68.03%
10 Year Est. Return
+174.56%
AUM
$294M
AUM Growth
-$16.5M
(-5.3%)
Cap. Flow
-$20.7M
Cap. Flow
% of AUM
-7.03%
Top 10 Holdings %
Top 10 Hldgs %
38.31%
Holding
75
New
1
Increased
14
Reduced
45
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$3.45M |
| 2 |
Hershey
HSY
|
+$3.15M |
| 3 |
Schwab International Dividend Equity ETF
SCHY
|
+$2.74M |
| 4 |
Verizon
VZ
|
+$1.51M |
| 5 |
SPDR Gold Trust
GLD
|
+$1.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Treasury Floating Rate Bond ETF
TFLO
|
+$4.37M |
| 2 |
Walmart Inc
WMT
|
+$3.52M |
| 3 |
Pfizer
PFE
|
+$2.69M |
| 4 |
Brown-Forman Class B
BF.B
|
+$2.34M |
| 5 |
iShares iBonds Dec 2029 Term Corporate ETF
IBDU
|
+$2.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 15.47% |
| 2 | Healthcare | 12.02% |
| 3 | Technology | 11.14% |
| 4 | Energy | 10.65% |
| 5 | Financials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.54T
| $16.8M | 5.69% |
75,415
-2,022
| -3% | -$468K |
|
|
2
Walmart Inc
WMT
$885B
| $14.6M | 4.95% |
165,748
-37,480
| -18% | -$3.52M |
|
3
ExxonMobil
XOM
$644B
| $12.3M | 4.18% |
103,401
-2,733
| -3% | -$302K |
|
4
Chubb
CB
$135B
| $11.5M | 3.93% |
38,243
-440
| -1% | -$122K |
|
5
Johnson & Johnson
JNJ
$618B
| $11.1M | 3.76% |
66,719
-160
| -0.2% | -$25K |
|
6
ConocoPhillips
COP
$147B
| $9.95M | 3.38% |
94,715
+1,190
| +1% | +$119K |
|
7
Alphabet (Google) Class C
GOOG
$4.36T
| $9.87M | 3.35% |
63,172
-985
| -2% | -$180K |
|
8
Procter & Gamble
PG
$336B
| $9.75M | 3.31% |
57,207
-8,605
| -13% | -$1.44M |
|
9
Microsoft
MSFT
$3.45T
| $9.04M | 3.07% |
24,079
-670
| -3% | -$273K |
|
10
Chevron
CVX
$392B
| $7.91M | 2.69% |
47,286
-195
| -0.4% | -$30.5K |
|
|
BNY
11
Bank of New York Mellon
BNY
$106B
| $7.85M | 2.67% |
93,620
-4,370
| -4% | -$367K |
|
12
Merck
MRK
$322B
| $7.72M | 2.62% |
85,971
-2,233
| -3% | -$208K |
|
13
Illinois Tool Works
ITW
$82.6B
| $7.33M | 2.49% |
29,570
-375
| -1% | -$96.4K |
|
14
Coca-Cola
KO
$377B
| $7M | 2.38% |
97,783
-440
| -0.4% | -$29.4K |
|
15
McDonald's
MCD
$192B
| $6.85M | 2.33% |
21,929
-208
| -0.9% | -$62.2K |
|
16
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.84B
| $6.38M | 2.17% |
264,018
-74,937
| -22% | -$1.8M |
|
17
Union Pacific
UNP
$174B
| $6.25M | 2.13% |
26,468
-368
| -1% | -$88.6K |
|
18
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.44B
| $6.11M | 2.08% |
252,444
-69,896
| -22% | -$1.69M |
|
19
iShares iBonds Dec 2028 Term Corporate ETF
IBDT
$4.06B
| $5.99M | 2.03% |
236,985
-69,750
| -23% | -$1.75M |
|
|
IBDQ
20
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
| $5.92M | 2.01% |
235,283
-65,644
| -22% | -$1.65M |
|
21
Honeywell
HON
$77B
| $5.63M | 1.91% |
28,199
+286
| +1% | +$57.9K |
|
22
Amgen
AMGN
$208B
| $5.54M | 1.88% |
17,771
+1,025
| +6% | +$303K |
|
23
JPMorgan Chase
JPM
$935B
| $5.4M | 1.84% |
22,027
-5,220
| -19% | -$1.33M |
|
24
Consolidated Edison
ED
$40.1B
| $5.36M | 1.82% |
48,487
+8,247
| +20% | +$809K |
|
|
25
SPDR Gold Trust
GLD
$131B
| $5.09M | 1.73% |
17,658
+4,468
| +34% | +$1.18M |
|
Similar funds
VIA
RC
MS
WI
HS
MA
SIAG
BHBT
Hamel Associates's Q1 2025 Portfolio in Review
As of Q1 2025, Hamel Associates held 75 positions worth $294M, down 5.3% from $311M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Hamel Associates withdrew a net $20.7M in Q1 2025, closing 4 positions and reducing 45 holdings. Its most notable exit was Brown-Forman Class B, an estimated $2.34M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Hamel Associates opened a new position in Bristol-Myers Squibb worth $220K.
- Hamel Associates's largest Q1 2025 buy was Bristol-Myers Squibb: 3,602 shares worth $220K.
- Hamel Associates added most to Novartis in Q1 2025, an estimated $3.45M increase.
- Hamel Associates's biggest Q1 2025 reduction was iShares Treasury Floating Rate Bond ETF, cutting an estimated $4.37M.
- Hamel Associates fully exited Brown-Forman Class B in Q1 2025, selling an estimated $2.34M.
- Hamel Associates's ten largest holdings make up 38% of its $294M portfolio in Q1 2025.
- Hamel Associates opened 1 new position and closed 4 in Q1 2025.
- Hamel Associates's portfolio value fell 5.3% quarter-over-quarter to $294M.
Based on Hamel Associates's 13F filing for Q1 2025, filed 6 May 2025.